Fibronectin and colorectal cancer: signaling pathways and clinical implications
Authors:
- 9 September 2020
- journal article
- other
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 41 (4) , 313-320
Abstract
Colorectal cancer (CRC) is the fourth leading cause of cancer deaths worldwide, with poor prognosis mainly related to metastasis. Fibronectin (FN), a vital component of the extracellular matrix (ECM), has been found involved in tumorigenesis and malignant progression in different types of malignancy. Numerous studies have indicated the distinct expression of FN in various cancers and demonstrated the different functions of FN in the proliferation, migration, and invasion of cancers. Meanwhile, FN isoforms have been extensively used for targeted drug delivery and imaging for tumors. Although a growing number of studies on FN in CRC have been reported, integrated reviews on the relationship between FN and CRC are rare. In this review, we will summarize the association between FN and CRC, including the signaling pathways and molecules involved in, as well as potential diagnostic and therapeutic values of FN for patients with CRC.Keywords
This publication has 92 references indexed in Scilit:
- A colorectal cancer classification system that associates cellular phenotype and responses to therapyNature Medicine, 2013
- Relationship between the Expression of the Extracellular Matrix Genes SPARC, SPP1, FN1, ITGA5 and ITGAV and Clinicopathological Parameters of Tumor Progression and Colorectal Cancer DisseminationOncology, 2012
- RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasisNature, 2012
- The Extra Domain A of Fibronectin Increases VEGF-C Expression in Colorectal Carcinoma Involving the PI3K/AKT Signaling PathwayPLOS ONE, 2012
- Plasma and cellular fibronectin: distinct and independent functions during tissue repairFibrogenesis & Tissue Repair, 2011
- A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancerHead & Neck Oncology, 2011
- Population-Based Family History–Specific Risks for Colorectal Cancer: A Constellation ApproachGastroenterology, 2010
- Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screeningBritish Journal of Cancer, 2010
- A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRIBioconjugate Chemistry, 2008
- Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour modelsBritish Journal of Cancer, 2007